Roche has announced positive topline data from the Phase III CENTERSTONE clinical trial of Xofluza (baloxavir marboxil), an ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an ...

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

Baloxavir marboxil significantly reduced the likelihood of influenza transmission from the infected patient to the household contacts. Treatment with baloxavir marboxil significantly reduced the risk ...

Respiratory illnesses like influenza and COVID can change rapidly, requiring the nimble development and delivery of antiviral ...

According to the Centers for Disease Control and Prevention, 35 million illnesses, 400,000 hospitalizations and 25,000 deaths ...

The Centers for Disease Control is warning that a drop in vaccinations in the U.S. may have increased flu deaths among ...

Chronic health conditions can be made worse by the flu, particularly those that tax your immune system and its ability to ...

CENTERSTONE is the first global Phase III study to show a transmission reduction benefit with an antiviral used in the treatment of a respiratory viral illness. This new data may add to the benefits ...

Health officials on Thursday said they don’t know how a Missouri person caught bird flu but believe it may be a rare instance ...

Treatment" program for its members in partnership with its MDLIVE unit. | Cigna is rolling out a new "E-Treatment" program ...